![]() |
Lung Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Interreader Agreement of Lung-RADS: A Systematic Review and Meta-Analysis.
AJR Am J Roentgenol. 2025;224:e2532681.
PubMed
Abstract available
Does Size Outweigh Number in Predicting Survival After Pulmonary Metastasectomy
for Soft Tissue Sarcoma? Insights from a Retrospective Multicenter Study.
Ann Surg Oncol. 2025;32:5948-5956.
PubMed
Abstract available
Analysis of Multiple Programmed Cell Death Patterns and Functional Validations of
Apoptosis-Associated Genes in Lung Adenocarcinoma.
Ann Surg Oncol. 2025;32:6005-6022.
PubMed
Abstract available
Deep learning-based lung cancer classification of CT images.
BMC Cancer. 2025;25:1056.
PubMed
Abstract available
Efficacy of PD-(L)1 inhibitors plus anlotinib in the second-line treatment of
extensive-stage small cell lung cancer.
BMC Cancer. 2025;25:1070.
PubMed
Abstract available
Steps towards overcoming challenges in clinical practice at 1.5T MR-Linac for
lung cancer adaptive radiotherapy.
BMC Cancer. 2025;25:1034.
PubMed
Abstract available
Efficacy and safety of first-line chemoimmunotherapy in young patients with
extensive-stage small cell lung cancer: a multicenter retrospective study.
BMC Cancer. 2025;25:1136.
PubMed
Abstract available
Immunotherapy concurrently administered with chemoradiotherapy in limited-stage
small-cell lung cancer.
BMC Cancer. 2025;25:1077.
PubMed
Abstract available
The probability of lung cancer in patients with pulmonary nodules detected via
low-dose computed tomography screening in China.
BMC Cancer. 2025;25:1058.
PubMed
Abstract available
Nomogram based on the advanced lung cancer inflammation index and other relevant
clinical factors for patients with cervical squamous cell carcinoma undergoing
concurrent chemoradiotherapy.
BMC Cancer. 2025;25:1043.
PubMed
Abstract available
Deep learning radiomics and mediastinal adipose tissue-based nomogram for
preoperative prediction of postoperative? brain metastasis risk in non-small cell
lung cancer.
BMC Cancer. 2025;25:1133.
PubMed
Abstract available
SCD1 Inhibition Blocks the AKT-NRF2-SLC7A11 Pathway to Induce Lipid Metabolism
Remodeling and Ferroptosis Priming in Lung Adenocarcinoma.
Cancer Res. 2025;85:2485-2503.
PubMed
Abstract available
Novel TEAD1 Inhibitor VT103 Enhances Dabrafenib Efficacy in BRAF V600E Mutated
Lung Adenocarcinoma via Survivin Downregulation.
Cancer Sci. 2025;116:1883-1896.
PubMed
Abstract available
Segmentectomy versus Lobectomy for Patients with 2-3cm Non-Small-Cell Lung
Cancer.
Chest. 2025 Jun 29:S0012-3692(25)00812-8. doi: 10.1016/j.chest.2025.
PubMed
Abstract available
Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in
Pleural Mesothelioma.
Clin Cancer Res. 2025;31:2639-2654.
PubMed
Abstract available
Liquid and Tissue Biopsies for Identifying MET Exon 14 Skipping NSCLC: Analyses
from the Phase II VISION Study of Tepotinib.
Clin Cancer Res. 2025;31:2675-2684.
PubMed
Abstract available
Osimertinib as First-Line Treatment for Patients With Advanced EGFR
Mutation-Positive Non-Small Cell Lung Cancer in a Real-World Setting: Updated
Overall Survival Data (OSI-FACT-OS).
Clin Lung Cancer. 2025 Jun 10:S1525-7304(25)00129.
PubMed
Abstract available
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive
Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status.
Clin Lung Cancer. 2025 Jun 6:S1525-7304(25)00128.
PubMed
Abstract available
Maximizing Lung Cancer Screening in High-Risk Population Leveraging ML-Developed
Risk-Prediction Algorithms: Danish Retrospective Validation of LungFlag.
Clin Lung Cancer. 2025 Jun 4:S1525-7304(25)00130.
PubMed
Abstract available
Systematic lymph node dissection for early-stage non-small cell lung cancer: One
size does not fit all.
Eur J Cardiothorac Surg. 2025 Jul 2:ezaf147. doi: 10.1093.
PubMed
Incidence and resource burden for the management of computed tomography-detected
ground glass opacities at a tertiary lung cancer service in the United Kingdom.
Eur J Cardiothorac Surg. 2025 Jul 4:ezaf223. doi: 10.1093.
PubMed
Abstract available
Comprehensive analysis of a real-world cohort identifies geranylgeranyl
diphosphate synthase 1 as a predictor of chemoresistance in small cell lung
cancer.
Int J Cancer. 2025 Jul 4. doi: 10.1002/ijc.70036.
PubMed
Abstract available
Low-dose radiotherapy concurrent with atezolizumab and chemotherapy as first-line
treatment for extensive-stage small-cell lung cancer: 3-year follow-up of a
multicenter, single-arm, phase 2 trial (MATCH).
Int J Radiat Oncol Biol Phys. 2025 Jul 1:S0360-3016(25)04508.
PubMed
Abstract available
Small cell lung cancer differentiation in patients with driver mutant non-small
cell lung cancer: a single center experience.
J Cancer Res Clin Oncol. 2025;151:199.
PubMed
Abstract available
The aryl hydrocarbon receptor controls IFN-gamma-induced immune checkpoints PD-L1 and
IDO via the JAK/STAT pathway in lung adenocarcinoma.
J Immunol. 2025;214:413-432.
PubMed
Abstract available
Interpreting survival comparisons in stage III non-small cell lung cancer:
Performance bias and the need for subgroup-specific analysis.
J Thorac Cardiovasc Surg. 2025 Jul 2:S0022-5223(25)00473.
PubMed
Transforming lung cancer diagnosis: the role of robotic-assisted bronchoscopy in
early detection and staging.
Lung Cancer. 2025;206:108646.
PubMed
Abstract available
Phase III study of ramucirumab plus docetaxel versus atezolizumab for previously
treated PD-L1 low or negative advanced non-small-cell lung cancer: WJOG10317L
study.
Lung Cancer. 2025;206:108633.
PubMed
Abstract available
Durvalumab plus irinotecan + cisplatin for untreated extensive-stage small cell
lung cancer: REBORN, phase II study (WJOG13520L).
Lung Cancer. 2025;206:108637.
PubMed
Abstract available
Nonagenarians: Outcomes after lung cancer surgery.
Lung Cancer. 2025;206:108632.
PubMed
Abstract available
The effectiveness of pembrolizumab maintenance with or without pemetrexed after
induction treatment for advanced non-squamous Non-Small-Cell Lung cancer.
Lung Cancer. 2025;206:108642.
PubMed
Abstract available
Advances in the treatment of brain metastases in EGFR-mutant non-small cell lung
cancer.
Lung Cancer. 2025;206:108641.
PubMed
Abstract available
MRD status combined with TNM staging optimizes postoperative prognostic
stratification in non-small cell lung cancer: a meta-analysis and systematic
review.
Lung Cancer. 2025;206:108634.
PubMed
Abstract available
Spatial multi-omics profiling of breast cancer oligo-recurrent lung metastasis.
Oncogene. 2025 Apr 15. doi: 10.1038/s41388-025-03388.
PubMed
Abstract available
Induction of IL6/STAT3-dependent TRAIL expression that contributes to the
therapeutic efficacy of osimertinib in EGFR mutant NSCLC cells.
Oncogene. 2025;44:2315-2327.
PubMed
Abstract available
Integrative epigenome and transcriptome analyses reveal transcriptional programs
differentially regulated by ASCL1 and NEUROD1 in small cell lung cancer.
Oncogene. 2025 Jul 1. doi: 10.1038/s41388-025-03481.
PubMed
Abstract available
Utility And Real-World Clinical Outcomes Of Next-Generation Sequencing In
Advanced Non-Small-Cell Lung Cancer In South Indian Population.
Oncologist. 2025 Jul 1:oyaf168. doi: 10.1093.
PubMed
Abstract available
KRAS mutated NSCLC: past, present, and future directions in a rapidly evolving
landscape.
Oncologist. 2025;30:oyaf153.
PubMed
Abstract available
Therapeutic patterns and outcomes in older patients (aged >/= 65 years) with stage
III inoperable non-small cell lung cancer (NSCLC): An investigational study from
the SEER database.
PLoS One. 2025;20:e0327458.
PubMed
Abstract available
Next-Generation Sequencing (NGS) in non-small cell lung carcinoma: A real-world
experience in the public health system of Galicia (Northwest Spain).
PLoS One. 2025;20:e0326336.
PubMed
Abstract available
Thank you for your interest in scientific medicine.